Emergent BioSolutions IncAdd to My Watchlist

EBS:USNew YorkIndustry: Medical-Biomedical/Gene
  • 35.78
  • 1.09  -2.96%
    Today's Change
  • 36.87
    Previous Close
  • Today
    52 Week Low - High
8:04 pm ET 2/5/2016
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding39 million
Market Cap$1 billion
Return on Equity ttm10.66%
Last DividendEBS:US does not pay a dividend
EPS: Year Actual ttm1.296
EPS: Year Est. 12/15 ttm1.453
EPS: Quarterly Actual 9/15 0.83
EPS: Quarterly Est. 12/15 0.65
Price/Earnings ttm27.60
Relative Price/Earnings1.630
Earnings Growth Rate13.95
Company Description
Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company. The Company develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. Emergent also develops and commercializes therapeutics and other specialty products for hospitals and clinics.
Revenue$450 million
Net Income$37 million
Total Assets$945 million
Web Sitewww.emergentbiosolutions.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!